Literature DB >> 6654538

Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection.

K N Masihi, W Brehmer, W Lange, E Ribi.   

Abstract

The nonspecific protective effect in mice of pre-exposure to mycobacterial components and muramyl dipeptide three weeks before aerosol infection with influenza virus A/PR/8/34 (H1N1) was studied. Muramyl dipeptide, when combined with trehalose dimycolate and emulsified in an oil-in-water emulsion, conferred complete protection comparable to specific immunization with a high dose of formalin inactivated A/PR/8/34 influenza viral vaccine. Animals pre-exposed to muramyl dipeptide plus trehalose dimycolate showed a marked reduction in lung virus titres, an earlier clearance of detectable infectious virus, and an earlier onset of antibody production in comparison to control mice. Resistance to infection was also observed with BCG-cell wall skeleton combined with trehalose dimycolate and trehalose dimycolate alone when given as oil-in-water preparations. The route of administration of nonspecific stimulants was crucial. Only intravenous but not intradermal inoculation produced significant protection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6654538     DOI: 10.1016/0192-0561(83)90015-2

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  8 in total

Review 1.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

2.  Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide.

Authors:  K N Masihi; W Brehmer; W Lange; H Werner; E Ribi
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

3.  Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets.

Authors:  K N Masihi; W Lange; B Rohde-Schulz
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.

Authors:  K N Masihi; W Brehmer; I Azuma; W Lange; S Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice.

Authors:  Pablo D Becker; Miriam Nörder; Carlos A Guzmán; Saul Grinstein
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

6.  Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.

Authors:  François Coulombe; Stéphanie Fiola; Shizuo Akira; Yvon Cormier; Jean Gosselin
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

7.  Muramyl peptides confer hepatoprotection against murine viral hepatitis.

Authors:  K N Masihi; H Kröger; W Lange; L Chedid
Journal:  Int J Immunopharmacol       Date:  1989

8.  Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination.

Authors:  Jun Dai; Decui Pei; Baoning Wang; Yu Kuang; Laifeng Ren; Kang Cao; Huan Wang; Bin Zuo; Jingjing Shao; Sha Li; Hong Li; Mingyuan Li
Journal:  Viruses       Date:  2012-12-10       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.